Company intelligence / Profile preview

Ramius Capital Group

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Ramius Capital Group was a prominent alternative investment management firm that became a significant force in the life sciences sector through its activist investment strategies and specialized healthcare funds. Founded in 1994 by Peter Cohen, the firm gained notoriety in the biotech industry for taking substantial positions in undervalued companies and pushing for strategic changes, such as its high-profile hostile bid for Cypress Bioscience. In 2009, Ramius merged with Cowen Group to form a diversified financial services firm, which significantly expanded its healthcare investment banking and research capabilities. Today, the legacy of Ramius's healthcare focus continues under the TD Cowen brand, following TD Bank's acquisition of Cowen in 2023.

Industry: Investors

Beyond the preview

Go deeper on Ramius Capital Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ramius Capital Group.

Explore the full profile